Studies
Planned and ongoing studies on Pulmonary Hypertension in Switzerland
See also: Reviews on studies in literature
For further information please contact the investigators.
Eisenmenger Study
Bosentan in PAH-patients with Eisenmenger's disease.
Further information: Prof. Maurice Beghetti, HUG Genève, maurice.beghetti@hcuge.ch
MOB
Assessment of PAH by an improved 6-minute-walk-test and mobile ergospirometry; test conditions with or without bosentan.
Further information: Prof. Michael Tamm, Dept. of Pneumology, University Hospital Basle, mtamm@uhbs.ch
SERIPH
Serotonin-Reuptake-Inhibitors in PH
Study on the effect of additive fluoxetine in PAH and the prevalence of depression and 5-HHT LL polymorphism.
Further information: Dr. Silvia Ulrich, University Hospital Zürich, Dept. of Internal Medicine, silvia.ulrich@usz.ch
See also: Reviews on studies in literature
For further information please contact the investigators.
Eisenmenger Study
Bosentan in PAH-patients with Eisenmenger's disease.
Further information: Prof. Maurice Beghetti, HUG Genève, maurice.beghetti@hcuge.ch
MOB
Assessment of PAH by an improved 6-minute-walk-test and mobile ergospirometry; test conditions with or without bosentan.
Further information: Prof. Michael Tamm, Dept. of Pneumology, University Hospital Basle, mtamm@uhbs.ch
SERIPH
Serotonin-Reuptake-Inhibitors in PH
Study on the effect of additive fluoxetine in PAH and the prevalence of depression and 5-HHT LL polymorphism.
Further information: Dr. Silvia Ulrich, University Hospital Zürich, Dept. of Internal Medicine, silvia.ulrich@usz.ch
Druckversion
Suche
5th International Congress of the Swiss Society of Pulmonary Hypertension (SSPH)
28.-29. September 2012, Thun, Congress Hotel Seepark Thun
Informationen: www.imk.ch/sgph2012
SSPH Research Prize 2012
Deadline for submission: April 30, 2012
Further information
mehr